In focus · trending topic

Aslan Pharmaceuticals

8 stories · following the connections

ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares

By Nasdaq OMXMay 4, 2018, 2:59 PM UTC

ASLAN Pharmaceuticals Announces Presentation of New Pre-Clinical Data on Varlitinib in Hepatocellular Carcinoma at AACR

By Nasdaq OMXApr 17, 2018, 1:29 PM UTC

Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

By Nasdaq OMXMar 27, 2018, 1:00 AM UTC

ASLAN Pharmaceuticals Sponsors Cholangiocarcinoma Foundation Annual Conference 2018

By Nasdaq OMXJan 31, 2018, 6:00 AM UTC

ASLAN Pharmaceuticals Appoints Stephen Doyle as Head of China

By Nasdaq OMXJan 18, 2018, 6:00 AM UTC

ASLAN Pharmaceuticals Announces Shortened Timeline to Commercialisation for Varlitinib in China

By Nasdaq OMXJan 8, 2018, 6:00 AM UTC

ASLAN Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

By Nasdaq OMXJan 4, 2018, 7:00 AM UTC

ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma

By Nasdaq OMXJan 3, 2018, 8:00 AM UTC